About lanadelum ab
Plasma kallikrein inhibitor
Used for
- Prevention of hereditary angioedema attacks in adults and children aged 2 years and older
Usual adult dose
300 mg injected under the skin every 2 weeks; some well-controlled adults may use every 4 weeks.
Usual dose in children
Ages 2–11: dose and schedule depend on body weight; given under the skin every 2 or 4 weeks.
Common side effects
- Injection-site reactions
- Headache
- Dizziness
- Muscle pain
Important warnings
- For prevention, not treatment of an acute attack.
- Serious allergic reactions, including anaphylaxis, can occur.
- People with hereditary angioedema should keep medication for acute attacks available.
Pregnancy
Human pregnancy data are limited; use only when clearly needed after weighing potential benefits and risks.
Breastfeeding
It is not known whether lanadelumab passes into breast milk; discuss benefits and risks with a clinician.
Interactions
- No established clinically significant drug interactions are known.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.